These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 25071021)
1. HERG1 functions as an oncogene in pancreatic cancer and is downregulated by miR-96. Feng J; Yu J; Pan X; Li Z; Chen Z; Zhang W; Wang B; Yang L; Xu H; Zhang G; Xu Z Oncotarget; 2014 Jul; 5(14):5832-44. PubMed ID: 25071021 [TBL] [Abstract][Full Text] [Related]
2. hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma. Lastraioli E; Perrone G; Sette A; Fiore A; Crociani O; Manoli S; D'Amico M; Masselli M; Iorio J; Callea M; Borzomati D; Nappo G; Bartolozzi F; Santini D; Bencini L; Farsi M; Boni L; Di Costanzo F; Schwab A; Onetti Muda A; Coppola R; Arcangeli A Br J Cancer; 2015 Mar; 112(6):1076-87. PubMed ID: 25719829 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-127 is aberrantly downregulated and acted as a functional tumor suppressor in human pancreatic cancer. Yu Y; Liu L; Ma R; Gong H; Xu P; Wang C Tumour Biol; 2016 Oct; 37(10):14249-14257. PubMed ID: 27571739 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-215 functions as a tumor suppressor and directly targets ZEB2 in human pancreatic cancer. Li QW; Zhou T; Wang F; Jiang M; Liu CB; Zhang KR; Zhou Q; Tian Z; Hu KW Genet Mol Res; 2015 Dec; 14(4):16133-45. PubMed ID: 26662405 [TBL] [Abstract][Full Text] [Related]
5. miR-493 inhibits proliferation and invasion in pancreatic cancer cells and inversely regulated hERG1 expression. Zhi D; Zhao X; Dong M; Yan C Oncol Lett; 2017 Dec; 14(6):7398-7404. PubMed ID: 29344180 [TBL] [Abstract][Full Text] [Related]
6. Harnessing the hERG1/β1 Integrin Complex via a Novel Bispecific Single-chain Antibody: An Effective Strategy against Solid Cancers. Duranti C; Iorio J; Lottini T; Lastraioli E; Crescioli S; Bagni G; Lulli M; Capitani C; Bouazzi R; Stefanini M; Carraresi L; Iamele L; De Jonge H; Arcangeli A Mol Cancer Ther; 2021 Aug; 20(8):1338-1349. PubMed ID: 34045227 [TBL] [Abstract][Full Text] [Related]
7. Silencing of herg gene by shRNA inhibits SH-SY5Y cell growth in vitro and in vivo. Zhao J; Wei XL; Jia YS; Zheng JQ Eur J Pharmacol; 2008 Jan; 579(1-3):50-7. PubMed ID: 17976575 [TBL] [Abstract][Full Text] [Related]
8. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway. Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361 [TBL] [Abstract][Full Text] [Related]
9. hERG1 channels regulate VEGF-A secretion in human gastric cancer: clinicopathological correlations and therapeutical implications. Crociani O; Lastraioli E; Boni L; Pillozzi S; Romoli MR; D'Amico M; Stefanini M; Crescioli S; Masi A; Taddei A; Bencini L; Bernini M; Farsi M; Beghelli S; Scarpa A; Messerini L; Tomezzoli A; Vindigni C; Morgagni P; Saragoni L; Giommoni E; Gasperoni S; Di Costanzo F; Roviello F; De Manzoni G; Bechi P; Arcangeli A Clin Cancer Res; 2014 Mar; 20(6):1502-12. PubMed ID: 24449824 [TBL] [Abstract][Full Text] [Related]
10. microRNA-1225 inhibit apoptosis of pancreatic cancer cells via targeting JAK1. Zhong R; Li S; Fang K; Yang L; Wang L Cell Cycle; 2019 May; 18(9):990-1000. PubMed ID: 30990343 [TBL] [Abstract][Full Text] [Related]
11. The role of hERG1 ion channels in epithelial-mesenchymal transition and the capacity of riluzole to reduce cisplatin resistance in colorectal cancer cells. Fortunato A Cell Oncol (Dordr); 2017 Aug; 40(4):367-378. PubMed ID: 28593575 [TBL] [Abstract][Full Text] [Related]
12. miR-133a functions as a tumor suppressor and directly targets FSCN1 in pancreatic cancer. Qin Y; Dang X; Li W; Ma Q Oncol Res; 2013; 21(6):353-63. PubMed ID: 25198665 [TBL] [Abstract][Full Text] [Related]
13. Prognostic role of hERG1 Potassium Channels in Neuroendocrine Tumours of the Ileum and Pancreas. Iorio J; Antonuzzo L; Scarpi E; D'Amico M; Duranti C; Messerini L; Sparano C; Caputo D; Lavacchi D; Borzomati D; Antonelli A; Nibid L; Perrone G; Coppola A; Coppola R; di Costanzo F; Lastraioli E; Arcangeli A Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142530 [TBL] [Abstract][Full Text] [Related]
14. A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4. Yang K; He M; Cai Z; Ni C; Deng J; Ta N; Xu J; Zheng J Pancreas; 2015 Apr; 44(3):370-9. PubMed ID: 25522282 [TBL] [Abstract][Full Text] [Related]
15. miR-663 attenuates tumor growth and invasiveness by targeting eEF1A2 in pancreatic cancer. Zang W; Wang Y; Wang T; Du Y; Chen X; Li M; Zhao G Mol Cancer; 2015 Feb; 14():37. PubMed ID: 25744894 [TBL] [Abstract][Full Text] [Related]
16. A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer. Marin-Muller C; Li D; Bharadwaj U; Li M; Chen C; Hodges SE; Fisher WE; Mo Q; Hung MC; Yao Q Clin Cancer Res; 2013 Nov; 19(21):5901-13. PubMed ID: 23989979 [TBL] [Abstract][Full Text] [Related]
17. hERG1 Potassium Channels: Novel Biomarkers in Human Solid Cancers. Lastraioli E; Lottini T; Bencini L; Bernini M; Arcangeli A Biomed Res Int; 2015; 2015():896432. PubMed ID: 26339650 [TBL] [Abstract][Full Text] [Related]
18. MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3. Zhao G; Zhang JG; Shi Y; Qin Q; Liu Y; Wang B; Tian K; Deng SC; Li X; Zhu S; Gong Q; Niu Y; Wang CY PLoS One; 2013; 8(9):e73803. PubMed ID: 24040078 [TBL] [Abstract][Full Text] [Related]
19. MiR-497 downregulation contributes to the malignancy of pancreatic cancer and associates with a poor prognosis. Xu J; Wang T; Cao Z; Huang H; Li J; Liu W; Liu S; You L; Zhou L; Zhang T; Zhao Y Oncotarget; 2014 Aug; 5(16):6983-93. PubMed ID: 25149530 [TBL] [Abstract][Full Text] [Related]